This activity is jointly provided by Global Education Group and American Society of Transplantation.

Target Audience

The educational design of this activity addresses the needs of healthcare professionals and researchers working in the field of transplantation medicine.

Statement of Need/Program Overview

Healthcare professionals and researchers who have dedicated their careers to transplant medicine continue to be challenged by a number of key questions pertaining to innovations in the field to address the challenges of lack of appropriate organs for transplant and patient outcomes - as assessed by both short-term and long-term survival. The program for CEOT 2015 was devised specifically to address these sometimes controversial issues and promote active dialogue between the stakeholders.

Educational Objective

After completing this activity, the participant should be better able to:

• Identify potential innovations in transplantation likely to improve patient outcomes in short-term future.
• Describe regulatory challenges for investigators and industry sponsors in drug development. 
• Identify opportunities for research programs or clinical collaborations to support their own research or clinical service.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Society of Transplantation. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Global Education Group designates this continuing education activity for 10.0 contact hour(s) (1.0 CEUs) of the Accreditation Council for Pharmacy Education. Below are the sessions that are approved for ACP credit. Each approved session will have its own UAN identification number. Please review the program for UANs or see below.

Session 1  0530-9999-15-005-L01-P
Session 2  0530-9999-15-006-L01-P
Session 6  0530-9999-15-007-L01-P
Session 7  0530-9999-15-008-L01-P
Session 8  0530-9999-15-009-L01-P
Unplenary 0530-9999-15-010-L01-P 

This is a knowledge-based activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 10.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Transplant Coordinator Continuing Education

This activity is pending approval from The American Board for Transplant Certification (AMTC). 

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

How to Claim Credit

Meeting attendees must complete an online evaluation form in order to request a certificate for any of the types of credit listed above, or for a general certificate of attendance. Please email Ben Thompson at bthompson@globaleducationgroup.com to request the link to the evaluation form. You will receive your certificate by email within 6-8 weeks of completing the evaluation.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. An information packet will be available that contains the faculty conflict of interest disclosures and other important information.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Planning Committee:
Anil Chandraker, MD - Grant Support: NIH, Alexion;  Consultant: UpToDate, RAPharma;  Paid Consultant: Dompe
Peiman Hematti, MD - Nothing to disclose
Anthony Jevnikar, MD - Nothing to disclose
Jonathan Maltzman, MD, PhD - Grant Support: American Heart Association;  Investments: GlaxoSmithKline;  Other: Morphotek
Kennthe Newell, MD, PhD - Grant Support: Novartis;  Consultant: Oxford Immunotech, SERC, Novartis;  Other: Novartis
Daniel Salomon, MD - Chief Scientific Advisor: Transplant Genomics Inc;  Grant Support: ThermoFisher/OneLambda, iGenomX;  Consultant: BMS, Amgen
Jason Wertheim, MD, PhD - Grant Support: NIH, ASTS, NKF of Illinois, American Association for the Study of Liver Diseases/ALF;  Honorarium: Provincial Health Services Authority, Center for the Advancement of Science in Space;  Contractor/Stipend: Landes Bioscience

Staff:
Ashley Marostica, RN, MSN - Nothing to disclose
Amanda Glazar, PhD - Nothing to disclose
Andrea Funk - Nothing to disclose
Tina Squillante, CMP - Nothing to disclose
Kristin Brammell, CMP - Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.    

Disclaimer  

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.